News
Public · Published
Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY
On Friday, Cathie Wood-led ARK Investment Management bought more Alphabet, AMD and Nvidia shares across its exchange-traded funds, alongside purchases in defense, aerospace and biotechnology stocks. The article's headline says ARK sold CoreWeave, Broadcom and Eli Lilly, while the article text provided does not detail those sales.
Published:
Updated:
What happened
On Friday, Cathie Wood-led ARK Investment Management bought more Alphabet, AMD and Nvidia shares across its exchange-traded funds, alongside purchases in defense, aerospace and biotechnology stocks. The article’s headline says ARK sold CoreWeave, Broadcom and Eli Lilly, while the article text provided does not detail those sales.
Confirmed
Global impact / market context
The purchases increase ARK funds’ exposure to large technology and semiconductor companies, so gains or losses in those holdings can more strongly affect fund returns. Buying defense, aerospace and biotechnology stocks also shifts portfolio exposure toward those industries, while the reported sales would reduce holdings in the named companies.
Analyst inference
The article describes buying in technology stocks despite a technology sell-off, but gives no dates, prices, trade sizes or performance data. That leaves the scale and financial impact unclear; the trades show ARK’s portfolio choices, not evidence that broader investors followed them.
Confirmed
What to watch
- Further fund disclosures could clarify the size and timing of purchases in Alphabet, AMD and Nvidia, helping investors assess how much these holdings influence ARK’s returns. Analyst inference
- The headline reports sales of CoreWeave, Broadcom and Eli Lilly, but the supplied article text gives no details; further reporting could specify amounts and funds involved. Confirmed
- Watch whether ARK continues adding to defense, aerospace and biotechnology holdings; repeated purchases would increase those industries’ weight in its funds and could magnify their effect on returns. Analyst inference